The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRentokil Initial Regulatory News (RTO)

Share Price Information for Rentokil Initial (RTO)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 410.10
Bid: 410.10
Ask: 410.30
Change: -8.20 (-1.96%)
Spread: 0.20 (0.049%)
Open: 417.50
High: 417.50
Low: 409.90
Prev. Close: 418.30
RTO Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Directorate Change

6 Nov 2017 07:00

RNS Number : 5632V
Rentokil Initial PLC
06 November 2017
 

6 November 2017

 

Appointment of Non-Executive Director

 

Rentokil Initial plc (FTSE: RTO, "the Company") today announces the appointment of John Pettigrew to its Board as a Non-Executive Director with effect from 1 January 2018. John will also become a member of the Audit Committee and the Nomination Committee from this date.

 

John is Chief Executive of National Grid plc, a FTSE 20 company. He joined National Grid in 1991 and progressed through a variety of roles before joining the Board as UK Executive Director in April 2014. He was appointed Chief Executive in April 2016. He has over 25 years of experience at National Grid in a variety of senior management roles, including Director of Engineering in the UK, Chief Operating Officer and Executive Vice President for the US Electricity Distribution & Generation business, Chief Operating Officer for UK Gas Distribution and UK Chief Operating Officer from 2012 to 2014. 

 

Prior to his appointment as Chief Executive of National Grid, John served on the UK Electricity and Gas licence entity boards. He was a Director for National Grid Electricity Transmission plc from September 2012 and of National Grid Gas plc from April 2011, becoming Chairman of both in 2015.

 

John is a Fellow of the Energy Institute and of the Institution of Energy and Technology. He holds a BSc in Economics and an MSc in International Economics and Banking. He also completed the Advanced Management Program at Harvard Business School in 2010.

 

Commenting on the appointment, John McAdam, Chairman of Rentokil Initial, said:

 

"We are delighted to welcome John to the Board of Rentokil Initial. His international experience of developing and implementing strategies for profitable growth, and in leading a business with a large field-based workforce, will be very valuable in the Company's continued development." 

 

There are no further details to be disclosed relating to John Pettigrew under Section 9.6.13 of the Listing Rules.

 

 

For further information please contact:

 

Rentokil Initial plc

Media

Malcolm Padley

07788 978199

Company Secretary

Daragh Fagan

01276 607444

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOAUGGCCGUPMGCW
Date   Source Headline
23rd Apr 20249:30 amRNSHolding(s) in Company
18th Apr 20247:00 amRNSQ1 Trading Update
2nd Apr 20241:28 pmRNSBlock listing Interim Review
2nd Apr 202412:17 pmRNSTotal Voting Rights
27th Mar 202410:23 amRNSAnnual Financial Report
19th Mar 20242:05 pmRNSAdditional Listing
14th Mar 202410:19 amRNSDirector/PDMR Shareholding
7th Mar 20247:00 amRNSFinal Results
1st Dec 20237:00 amRNSNorth American Management Changes
10th Nov 20232:28 pmRNSDirector/PDMR Shareholding
3rd Nov 20234:26 pmRNSHolding(s) in Company
3rd Nov 20234:22 pmRNSDirector/PDMR Shareholding
1st Nov 202312:50 pmRNSHolding(s) in Company
31st Oct 202311:45 amRNSHolding(s) in Company
30th Oct 20233:03 pmRNSDirector/PDMR Shareholding
30th Oct 202311:55 amRNSCredit rating update
19th Oct 20237:00 amRNSQ3 Trading Update
2nd Oct 202311:35 amRNSBlock listing Interim Review
27th Sep 20232:35 pmRNSDirector/PDMR Shareholding
1st Aug 202312:42 pmRNSDirector/PDMR Shareholding
27th Jul 20237:00 amRNS2023 Interim Results
29th Jun 20239:00 amRNSNotice of Management Presentation
23rd Jun 20235:58 pmRNSDirector/PDMR Shareholding
19th May 20233:03 pmRNSDirector/PDMR Shareholding
12th May 20239:09 amRNSDirector/PDMR Shareholding
11th May 20239:17 amRNSResult of AGM
28th Apr 202310:55 amRNSHolding(s) in Company
21st Apr 20232:41 pmRNSDirector/PDMR Shareholding
20th Apr 20237:00 amRNSQ1 Trading Update
4th Apr 20239:37 amRNSAnnual Financial Report
3rd Apr 202310:08 amRNSBlock listing Interim Review
23rd Mar 20239:42 amRNSDirector/PDMR Shareholding
20th Mar 20234:47 pmRNSDirector/PDMR Shareholding
16th Mar 20237:05 amRNSDirectorate Change
16th Mar 20237:00 amRNSFinal Results
9th Mar 20239:23 amRNSDirector Declaration
27th Feb 20238:55 amRNSNotice of Management Presentation
9th Nov 20224:33 pmRNSDirector Declaration
1st Nov 20222:25 pmRNSCorrection: Q3 Trading Update
1st Nov 20227:00 amRNSQ3 Trading Update
31st Oct 20224:03 pmRNSTotal Voting Rights
24th Oct 20225:15 pmRNSHolding(s) in Company
21st Oct 20224:42 pmRNSHolding(s) in Company
20th Oct 202212:35 pmRNSHolding(s) in Company
19th Oct 202211:43 amRNSHolding(s) in Company
18th Oct 20225:22 pmRNSHolding(s) in Company
17th Oct 20226:07 pmRNSHolding(s) in Company
17th Oct 202211:51 amRNSHolding(s) in Company
14th Oct 20224:39 pmRNSHolding(s) in Company
14th Oct 20224:37 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.